Morbidity and mortality in obstructive sleep apnea syndrome 1: Effect of treatment on cardiovascular morbidity

Sleep and Biological Rhythms

Volumn 1, Issue 1, 2003, Pages 15-28

  Shepertycky, Martha R ^a   Al Barrak, Mohammed ^b   Kryger, Meir H ^a  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

hypertension; ischemic heart disease; obstructive sleep apnea; stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; FIBRINOGEN; VASCULOTROPIN;

ANGIOGENESIS; AROUSAL; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE MEASUREMENT; BLOOD VISCOSITY; BODY MASS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORBIDITY; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPOXEMIA; ISCHEMIC HEART DISEASE; LUNG ARTERY PRESSURE; MENTAL DISEASE; MORBIDITY; NECK CIRCUMFERENCE; OBESITY HYPOVENTILATION SYNDROME; OXYGEN DESATURATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QT PROLONGATION; RESPIRATORY DISTURBANCE INDEX; REVIEW; RISK FACTOR; SLEEP DISORDERED BREATHING; SYMPATHETIC TONE; TRACHEOSTOMY; VASCULAR REMODELING; WAIST CIRCUMFERENCE;

EID: 84979884653     PISSN: 14469235     EISSN: 14798425     Source Type: Journal    
DOI: 10.1046/j.1446-9235.2003.00003.x     Document Type: Review

References (134)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 1993; 328: 1230–5.
2. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667–89.
3. Yamashiro Y, Kryger MH. Why should sleep apnea be diagnosed and treated. Clin. Pulm. Med. 1994; 1: 250–9.
4. Findley L, Unverzadt M, Suratt P. Automobile accidents in patients with obstructive sleep apnea. Am. Rev. Respir. Dis. 1988; 138: 337–40.
5. George C, Nickerson P, Hanly P, Millar T, Kryger M. Sleep apnoea patients have more automobile accidents. Lancet 1987; 8556: 447.
6. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ 1997; 314: 851–60.
7. Stradling JR, Davies RJ. The unacceptable face of evidence-based medicine (editorial). J. Eval. Clin. Pract. 1997; 3: 99–103.
8. Stradling J. Sleep apnoea and the misuse of evidence-based medicine. Lancet 1997; 349: 201–2.
9. Gibson GJ. Public health aspects of obstructive sleep apnea. Thorax 1998; 53: 408–9.
10. Al-Barrak M, Shepertycky M, Kryger MH. Morbidity and mortality in obstructive sleep apnea syndrome 2. Effect of treatment on neuropsychiatric morbidity and quality of life. Sleep and Biol. Rhythms (in press).
11. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea. Facts and theory. Am. J. Med. 1995; 98: 118–28.
12. Zwillich CW. Obstructive sleep apnea causes transient and sustained systemic hypertension. Int. J. Clin. Pract. 1999; 53: 301–5.
13. Young T, Peppard P, Palta M et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch. Intern. Med. 1997; 157: 1746–52.
14. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J. Clin. Invest. 1997; 99: 106–9.
15. Imagawa S, Yamaguchi Y, Higuchi M et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 2001; 98: 1255–7.
16. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am. J. Respir. Crit. Care Med. 2002; 165: 67–70.
17. Gozal D, Lipton AJ, Jones KL. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 2002; 25: 59–65.
18. Lavie L, Kraiczi H, Hefetz A et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am. J. Respir. Crit. Care Med. 2002; 165: 1624–8.
19. Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest 1991; 99: 861–6.
20. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 2000; 342: 1378–84.
21. Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283: 1829–36.
22. Smith R, Ronald J, Delaive K, Walld R, Manfreda J, Kryger MH. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest 2002; 121: 164–72.
23. Hirshkowitz M, Karacan I, Gurakar A, Williams RL. Hypertension, erectile dysfunction, and occult sleep apnea. Sleep 1989; 12: 223–32.
24. Williams AJ, Houston D, Finberg S, Lam C, Kinney JL, Santiago S. Sleep apnea syndrome and essential hypertension. Am. J. Cardiol. 1985; 55: 1019–22.
25. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am. Heart J. 1984; 108: 373–6.
26. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J. Hypertens. 2000; 18: 679–85.
27. Logan AG, Perlikowski SM, Mente A et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J. Hypertens. 2001; 19: 2271–7.
28. Stoohs RA, Gingold J, Cohrs S, Harter H, Finlayson E, Guillemnieault C. Sleep disordered breathing and systemic hypertension in the older male. J. Amer. Geriatric Soc. 1996; 44: 1295–300.
29. Isaksson H, Svanborg E. Obstructive sleep apnea syndrome in male hypertensives refractory to drug therapy. Nocturnal automatic blood pressure measurements — an aid to diagnosis? Clin. Exp. Hypertens. Theory and Practice 1991; A13: 1198–212.
30. Silverberg DS, Oksenberg A, Iaina A. Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated. Am. J. Hypertens. 1997; 10: 1319–25.
31. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest. 1995; 96: 1897–904.
32. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987; 10: 35–44.
33. Minemura H, Akashiba T, Yamamoto H, Akahoshi T, Kosaka N, Horie T. Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea. Intern. Med. 1998; 37: 1009–13.
34. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am. J. Respir. Crit. Care Med. 2001; 163: 344–8.
35. Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T. Nasal continuous positive airway pressure changes blood pressure ‘non-dippers’ to ‘dippers’ in patients with obstructive sleep apnea. Sleep 1999; 22: 849–53.
36. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in ‘non-dippers’. Sleep 1996; 19: 378–81.
37. Mayer J, Becker H, Brandenburg U, Penzel T, Peter JH, von Wichert P. Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology 1991; 79: 84–92.
38. Stradling JR, Partlett J, Davies RJO, Siegwart D, Tarassenko L. Effect of short term graded withdrawal of nasal continuous positive airway pressure on systemic blood pressure in patients with obstructive sleep apnea. Blood Press. 1996; 5: 234–40.
39. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am. J. Respir. Crit. Care Med. 2002; 166: 159–65.
40. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996; 109: 380–6.
41. Laks L, Lehrhaft B, Grunstein RR, Sullivan CE. Pulmonary hypertension in obstructive sleep apnoea. Eur. Respir. J. 1995; 8: 537–41.
42. Weitzenblum E, Krieger J, Apprill M et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am. Rev. Respir. Dis. 1988; 138: 345–9.
43. Sajkov D, Cowie RJ, Thornton AT, Espinoza HA, McEvoy RD. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 1994; 149: 416–22.
44. Faller DV. Endothelial cell responses to hypoxic stress. Clin. Exp. Pharmacol. Physiol. 1999; 26: 74–84.
45. Sajkov D, Wang T, Saunders NA, Bune AJ, Neill AM, Mcevoy DR. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am. J. Respir. Crit. Care Med. 1999; 159: 1518–26.
46. Guidry UC, Mendes LA, Evans JC et al. Echocardio-graphic features of the right heart in sleep-disordered breathing: the Framingham Heart Study. Am. J. Respir. Crit. Care Med. 2001; 164: 933–8.
47. Bradley TD, Rutherford R, Grossman RF et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am. Rev. Respir. Dis. 1985; 131: 835–9.
48. Sanner BM, Konermann M, Sturm A, Muller HJ, Zidek W. Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur. Respir. J. 1997; 10: 2079–83.
49. Motta J, Guilleminault C, Schroeder JS, Dement WC. Tracheostomy and hemodynamic changes in sleep induced apnea. Ann. Intern. Med. 1978; 89: 454–8.
50. Fletcher EC, Shaaf JW, Miller J, Gletcher JG. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am. Rev. Respir. Dis. 1987; 135: 525–37.
51. Sforza E, Krieger J, Weitzenblum E, Apprill M, Lampert E, Ratamaharo J. Long-term effects of treatment with nasal continuous positive airway pressure on daytime lung function and pulmonary hemodynamics in patients with obstructive sleep apnea. Am. Rev. Respir. Dis. 1990; 141: 866–70.
52. Chaouat A, Weitzenblum E, Kessler R et al. Five-year effects of nasal continuous positive airway pressure in obstructive sleep apnea syndrome. Eur. Respir. J. 1997; 10: 2578–82.
53. Lewis DF, Chesson AL, Edwards MS, Weeks JW, Adair CD. Obstructive sleep apnea during pregnancy resulting in pulmonary hypertension. South Med. J. 1998; 91: 761–2.
54. Sajkov D, Wang T, Saunders NA, Bune AJ, Mcevoy DR. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2002; 165: 152–8.
55. Kessler R, Chaouat A, Schinkewitch P et al. The obe-sity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001; 120: 369–76.
56. Sullivan CE, Berthon-Jones M, Issa FG. Remission of severe obesity-hypoventilation syndrome after short-term treatment during sleep with nasal continuous positive airway pressure. Am. Rev. Respir. Dis. 1983; 128: 177–81.
57. Lin CC. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnea syndrome. Eur. Respir. J. 1994; 7: 2005–10.
58. Berthon-Jones M, Sullivan CE. Time course change in ventilatory response to CO2 with long term CPAP therapy for obstructive sleep apnea. Am. Rev. Respir. Dis. 1987; 135: 144–7.
59. Rapoport DM, Garay SM, Epstein H, Goldring R. Hypercapnia in obstructive sleep apnea syndrome. A reevaluation of the Pickwickian syndrome. Chest 1986; 89: 627–35.
60. Kim SH, Eisele DW, Smith PL, Schneider H, Schwartz AR. Evaluation of patients with sleep apnea after tracheotomy. Arch. Otolaryngol. Head Neck Surg. 1998; 124: 996–1000.
61. Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health-care resources in obesity-hypoventi-lation syndrome. Chest 2001; 120: 377–83.
62. Guilleminault C, Connoly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbance during sleep in 400 patients with sleep apnea syndrome. Am. J. Cardiol. 1983; 52: 490–4.
63. Shepard JW, Garison MW, Grither DA, Dolan GF. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985; 88: 335–40.
64. Gillis AM, Stoohs R, Guilleminault C. Changes in QT interval during obstructive sleep apnea. Sleep 1991; 14: 346–50.
65. Harbison J, O’Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome. Chest 2000; 118: 591–5.
66. Stegman SS, Burroughs JM, Henthorn RW. Asymptomatic bradyarrhythmias as a marker of sleep apnea: appropriate recognition and treatment may reduce the need for pacemaker therapy. Pacing Clin. Electrophysiol. 1996; 19: 899–904.
67. Phillips BA, Schmitt FA, Berry DTR, Lamb DG, Amin M, Cook YR. Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest 1990; 98: 325–30.
68. Garrigue S, Bordier P, Jais P et al. Benefit of atrial pacing in sleep apnea syndrome. N. Engl. J. Med. 2002; 346: 404–12.
69. D’Alessandro R, Magelli C, Gamberini G et al. Snoring every night as a risk factor for myocardial infarction: a case control study. BMJ 1990; 300: 1557–8.
70. Partinen M, Alihanka J, Lang H, Kalliomaki L. Myocar-dial infarction in relation to sleep apneas. Sleep Res. 1983; 12: 272.
71. Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2001; 163: 19–25.
72. Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, Bende M. An independent association between sleep apnoea and coronary artery disease. Eur. Resp. J. 1999; 14: 179–84.
73. Newman AB, Spiekerman CF, Enright P et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J. Am. Geriatr. Soc. 2000; 48: 115–23.
74. Otake K, Delaive K, Walld R, Manfreda J, Kryger MH. Cardiovascular medication use in patients with undiag-nosed obstructive sleep apnoea. Thorax 2002; 57: 417–22.
75. Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999; 92: 79–84.
76. Mooe T, Franklin K, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease. Long term Prognosis. Am. J. Respir. Crit. Care Med. 2001; 164: 1910–13.
77. Peled N, Abinder EG, Pillar G, Sharif D, Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J. Am. Coll. Cardiol. 1999; 34: 1744–9.
78. Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnoea and nocturnal angina. Lancet 1995; 29: 1085–7.
79. Phillip P, Guilleminault C. ST segment abnormality, angina during sleep and obstructive sleep apnea. Sleep 1993; 16: 558–9.
80. Schafer H, Koehler U, Ploch T, Peter JH. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 1997; 111: 387–93.
81. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am. J. Respir. Crit. Care Med. 2000; 162: 81–6.
82. Peker YJ, Hedner A, Johansson A, Bende M. Reduced hospitalization due to cardiovascular and pulmonary disease in patients with obstructive sleep apnea on nasal CPAP treatment. Sleep 1997; 20: 645–53.
83. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven year follow-up in obstructive sleep apnea patients. Chest 1990; 97: 27–32.
84. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J. Am. Coll. Cardiol. 1993; 22 (Suppl. A): A6–13.
85. Bradley TD, Logan AG, Floras JS. Rationale and design of the Canadian Continuous Positive Airway Pressure Trial for Congestive Heart Failure patients with Central Sleep Apnea — CANPAP. Can. J. Cardiol. 2001; 17: 677–84.
86. Sin D, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am. J. Respir. Crit. Care Med. 1999; 160: 1101–6.
87. Fletcher EC, Proctor M, Yu J et al. Pulmonary edema develops after recurrent obstructive apneas. Am. J. Respir. Crit. Care Med. 1999; 160: 1688–96.
88. Parker JD, Brooks D, Kozar LF et al. Acute and chronic effects of airway obstruction on canine left ventricular performance. Am. J. Respir. Crit. Care Med. 1999; 160: 1888–96.
89. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J. Hypertens. 1990; 8: 941–6.
90. Niroumand M, Kuperstein R, Sasson Z, Hanly PJ. Impact of obstructive sleep apnea on left ventricular mass and diastolic function. Am. J. Respir. Crit. Care Med. 2001; 163: 1632–6.
91. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese patients with and without obstructive sleep apnea. Circulation 1998; 98: 1071–7.
92. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest. 1995; 96: 1897–904.
93. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J. Am. Coll. Cardiol. 1994; 23: 570–8.
94. Yan AT, Bradley TD, Liu PP. The role of continuous positive airway pressure in the treatment of congestive heart failure. Chest 2001; 120: 1675–85.
95. Malone S, Lie PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338: 1480–4.
96. Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet 1985; 2: 1325–6.
97. Palomaki H. Snoring and the risk of ischemic brain infarction. Stroke 1991; 22: 1021–5.
98. Neau J-P, Meurice J-C, Paquereau J, Chavagnat J-J, Ingrand P, Ril R. Habitual snoring as a risk factor for brain infarction. Acta Neurol. Scand. 1995; 92: 63–8.
99. Koskenvuo M, Kaprio J, Telakivi T, Partinen M, Heikkila K, Sarna S. Snoring as a risk factor for ischaemic heart disease and stroke in men. BMJ 1987; 294: 16–19.
100. Lip GY, Zarifis J, Farooqi IS, Page A, Sagar G, Beevers DG. Ambulatory blood pressure monitoring in acute stroke. The West Birmingham Stroke Project. Stroke 1997; 28: 31–5.
101. Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996; 27: 252–9.
102. Dyken ME, Somers VK, Yamada T, Ren Z-Y, Zimmerman B. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996; 27: 401–7.
103. Bassetti C, Aldrich MS. Sleep apnea in acute cere-brovascular diseases: final report on 128 patients. Sleep 1999; 22: 217–23.
104. Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, Diomedi M. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 2002; 33: 1782–5.
105. Siebler M, Nachtmann A. Cerebral hemodynamics in obstructive sleep apnea. Chest 1993; 103: 118–19.
106. Droste DW, Ludemann P, Anders F et al. Middle cerebral artery blood flow velocity, end-tidal pCO2 and blood pressure in patients with obstructive sleep apnea and in healthy subjects during continuous positive airway pressure breathing. Neurol. Res. 1999; 21: 737–41.
107. Fischer AQ, Chaudhary BA, Taormina MA, Akhtar B. Intracranial hemodynamics in sleep apnea. Chest 1992; 102: 1402–6.
108. Netzer N, Werner P, Jochmus I, Lehmann M, Strohl K. Blood flow of the middle cerebral artery with sleep disordered breathing. Stroke 1998; 29: 87–93.
109. Balfors EM, Franklin K. Impairment of cerebral perfusion during obstructive sleep apneas. Am. J. Respir. Crit. Care Med. 1994; 150: 1587–91.
110. Jennum P, Borgesen SE. Intracranial pressure and obstructive sleep apnea. Chest 1989; 95: 279–83.
111. Chin K, Ohi M, Kita H et al. Effects of nCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 1996; 153: 1972–6.
112. Shamsuzzaman ABM, Somers V. Fibrinogen stroke and obstructive sleep apnea. An evolving paradigm of cardiovascular risk. Am. J. Respir. Crit. Care Med. 2000; 162: 2018–20.
113. Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA 1987; 258: 1183–6.
114. Resch KL, Ernst E, Matrai A, Paulsen HF. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Ann. Intern. Med. 1992; 117: 371–5.
115. Wessendorf TE, Thilman AF, Wang Y-M, Schreiber A, Konietzko N, Teschler H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am. J. Respir. Crit. Care Med. 2000; 162: 2039–42.
116. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy. Chest 1995; 108: 625–30.
117. Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002; 69: 229–34.
118. Tofler GH, Brezinski D, Schafer AI et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden death. N. Engl. J. Med. 1987; 316: 1514–18.
119. Muller JE, Stone Ph, Turi ZG et al. Circadian variation in the frequency of onset of acute myocardial infarction. N. Engl. J. Med. 1985; 313: 1315–22.
120. Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 1995; 18: 377–81.
121. Wessendorf TE, Wang Y-M, Thilman AF, Sorgenfrei U, Konietzko N, Teschler H. Treatment of obstructive sleep apnoea with nasal continuous positive pressure in stroke. Eur. Respir. J. 2001; 18: 623–9.
122. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9–14.
123. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988; 94: 1200–4.
124. Noda A, Okada T, Yasuma F, Sobue T, Nakashima N, Yokota M. Prognosis of the middle-aged and aged patients with obstructive sleep apnea syndrome. Psychiatry Clin. Neurosci. 1998; 52: 79–85.
125. Lavie P, Herer P, Peled R et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18: 149–57.
126. Seppala T, Partinen M, Penttila A, Aspholm R, Tiainen E, Kaukianen A. Sudden death and sleeping history among Finnish men. J. Intern. Med. 1991; 229: 23–8.
127. Lindberg E, Janson C, Svardsudd K, Gislason T, Hetta J, Boman G. Increased mortality among sleepy snorers: a prospective population based study. Thorax 1998; 53: 631–7.
128. Veale D, Chailleux E, Hoorelbeke-Ramon A et al. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Association Nationale pour le Traitement A Domicile de l’Insuffisance Respiratoire chronique. Eur. Respir. J. 2000; 15: 326–31.
129. Bahammam A, Delaive K, Ronald J, Manfreda J, Roos L, Kryger MH. Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep 1999; 22: 740–7.
130. Fischer J, Raschke F. Economic and medical significance of sleep-related breathing disorders. Respiration 1997; 64: 39–44.
131. Reuveni H, Simon T, Tal A, Elhayany A, Tarasiuk A. Health care services utilization in children with obstructive sleep apnea syndrome. Pediatrics 2002; 110: 68–72.
132. Kapur VK, Redline S, Nieto FJ, Young TB, Newman AB, Henderson JA. The relationship between chronically disrupted sleep and healthcare use. Sleep 2002; 25: 289–96.
133. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomised prospective parallel trial. Lancet 1999; 19: 2100–5.
134. Bennett LS, Barbour C, Langford B, Stradling JR, Davies RJ. Health status in obstructive sleep apnea: relationship with sleep fragmentation and daytime sleepiness, and effects of continuous positive airway pressure treatment. Am. J. Respir. Crit. Care Med. 1999; 159: 1884–90.